Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 21

1.

Botulinum Neurotoxins: Biology, Pharmacology, and Toxicology.

Pirazzini M, Rossetto O, Eleopra R, Montecucco C.

Pharmacol Rev. 2017 Apr;69(2):200-235. doi: 10.1124/pr.116.012658. Review.

2.

Neutralization of Botulinum Neurotoxin Type E by a Humanized Antibody.

Derman Y, Selby K, Miethe S, Frenzel A, Liu Y, Rasetti-Escargueil C, Avril A, Pelat T, Urbain R, Fontayne A, Thullier P, Sesardic D, Lindström M, Hust M, Korkeala H.

Toxins (Basel). 2016 Sep 12;8(9). pii: E257. doi: 10.3390/toxins8090257.

3.

Botulinum Toxin Type a as a Therapeutic Agent against Headache and Related Disorders.

Luvisetto S, Gazerani P, Cianchetti C, Pavone F.

Toxins (Basel). 2015 Sep 23;7(9):3818-44. doi: 10.3390/toxins7093818. Review.

4.

Role of neurotoxin associated proteins in the low pH induced structural changes in the botulinum neurotoxin complex.

Chellappan G, Kumar R, Cai S, Singh BR.

Protein J. 2014 Dec;33(6):557-64. doi: 10.1007/s10930-014-9588-4.

5.

Isolation and quantification of botulinum neurotoxin from complex matrices using the BoTest matrix assays.

Dunning FM, Piazza TM, Zeytin FN, Tucker WC.

J Vis Exp. 2014 Mar 3;(85). doi: 10.3791/51170.

6.

Rare presentation of botulism with generalized fasciculations.

Arora A, Sharma CM, Kumawat B, Khandelwal D.

Int J Appl Basic Med Res. 2014 Jan;4(1):56-8. doi: 10.4103/2229-516X.125698.

7.

Long lasting dysautonomia due to botulinum toxin B poisoning: clinical-laboratory follow up and difficulties in initial diagnosis.

Potulska-Chromik A, Zakrzewska-Pniewska B, Szmidt-Sałkowska E, Lewandowski J, Siński M, Przyjałkowski W, Kostera-Pruszczyk A.

BMC Res Notes. 2013 Oct 30;6:438. doi: 10.1186/1756-0500-6-438.

8.

Clinically and electrophysiologically diagnosed botulinum intoxication.

Kotan D, Aygul R, Ceylan M, Yilikoglu Y.

BMJ Case Rep. 2013 Jan 3;2013. pii: bcr0120125678. doi: 10.1136/bcr.01.2012.5678.

9.

Clinical uses of botulinum neurotoxins: current indications, limitations and future developments.

Chen S.

Toxins (Basel). 2012 Oct;4(10):913-39. doi: 10.3390/toxins4100913. Epub 2012 Oct 19. Review.

10.

Fatal course of foodborne botulism in an eight-month old infant.

Lonati D, Locatelli CA, Fenicia L, Anniballi F, Landri P, Giampreti A, Petrolini VM, Vecchio S, Manzo L.

Pediatr Rep. 2011 Sep 30;3(4):e31. doi: 10.4081/pr.2011.e31. Epub 2011 Dec 2.

11.

Botulinum neurotoxin for pain management: insights from animal models.

Pavone F, Luvisetto S.

Toxins (Basel). 2010 Dec;2(12):2890-913. doi: 10.3390/toxins2122890. Epub 2010 Dec 21. Review.

12.

Botulinum toxin: bioweapon & magic drug.

Dhaked RK, Singh MK, Singh P, Gupta P.

Indian J Med Res. 2010 Nov;132:489-503. Review.

13.

Food-borne illnesses during pregnancy: prevention and treatment.

Tam C, Erebara A, Einarson A.

Can Fam Physician. 2010 Apr;56(4):341-3.

14.

An efficient drug delivery vehicle for botulism countermeasure.

Zhang P, Ray R, Singh BR, Li D, Adler M, Ray P.

BMC Pharmacol. 2009 Oct 27;9:12. doi: 10.1186/1471-2210-9-12.

15.

Stability of a trivalent recombinant protein vaccine formulation against botulinum neurotoxin during storage in aqueous solution.

Vessely C, Estey T, Randolph TW, Henderson I, Cooper J, Nayar R, Braun LJ, Carpenter JF.

J Pharm Sci. 2009 Sep;98(9):2970-93. doi: 10.1002/jps.21498.

16.

First case of type E wound botulism diagnosed using real-time PCR.

Artin I, Björkman P, Cronqvist J, Rådström P, Holst E.

J Clin Microbiol. 2007 Nov;45(11):3589-94. Epub 2007 Sep 19.

17.

Foodborne botulism in the Republic of Georgia.

Varma JK, Katsitadze G, Moiscrafishvili M, Zardiashvili T, Chikheli M, Tarkashvili N, Jhorjholiani E, Chubinidze M, Kukhalashvili T, Khmaladze I, Chakvetadze N, Imnadze P, Sobel J.

Emerg Infect Dis. 2004 Sep;10(9):1601-5.

18.

Clostridial neurotoxins.

Goonetilleke A, Harris JB.

J Neurol Neurosurg Psychiatry. 2004 Sep;75 Suppl 3:iii35-9. Review. No abstract available.

19.

Mysterious dysphagia.

Biggs MJ, Quick CA.

J R Soc Med. 2003 Nov;96(11):549-50. No abstract available.

20.

Botulism in Canada.

Weir E.

CMAJ. 2001 Feb 20;164(4):538. No abstract available.

Supplemental Content

Support Center